top of page
THE VISION

Paradigm shift in anastomotic technique

We innovate, manufacture and deliver

a new generation of surgical instruments

for colorectal surgery

The Vision
HISTORY
tidslinje.png
tidslinje.png
tidslinje.png
tidslinje.png

The start 2006

CarpoNovum is founded by
two colorectal surgeons 
Prof. Henrik Thorlacius, MD, PhD and

Anders Grönberg, MD, PhD, engineer

Award 2006

CarpoNovum received

Öhrlings Price Water House Coopers and LUIS Innovation awards

Award 2007

CarpoNovum received the
national Skapa
Development Award

Award 2007

CarpoNovum received the
award for the most successful company in the Connect
Sweden network

2007.png

CE 2011

CARP®, predecessor
of C-REX®, received
CE marking

Developing 2011-2018

C-REX® device family was developed, clinical studies were conducted in Sweden, Denmark and China.

2011.png

CE 2018

CE mark is warded to the
C-REX® portfolio

2018.png
2020.png

Scandinavian CCS 2020

A subsidiary of CarpoNovum AB,
is formed for surgical
education and
clinical practice.

Clinical trial in Malmö,
Sweden
 
2023

Investigator initiated study successfully finalized, see article.

http://link.springer.com/article/10.1007/s00384-023-04420-x

2023.png
2006.png
test_1.png
test_3.png

Anders Grönberg

Henrik  Thorlacius

History
ABOUT

CarpoNovum is a Swedish company innovating, manufacturing and delivering a new generation of surgical instruments for colorectal surgery.

 

Company’s headquarters, in-house R&D and manufacturing facilities are located in Halmstad, Sweden.

About
BOARD OF DIRECTORS
Board of directors

Otto Drakenberg

Chairman of the Board

Otto Drakenberg is a Stockholm based CEO and Board Chairman with extensive experience leading complex transformations in a range of industry sectors such as consumer goods, retail, consumer service and technology. Otto is the chairman of the board of Spendrups Brewery, Svegro and Sisjö Intressenter and was until 2022 Group CEO of Scandi Standard. His former operational roles include CEO of Carlsberg Sweden, Group CEO of the Nordic wine and liquor group Arcus, Chairman of the Board and leader of the reconstruction and sale of the retail chain Twilfit, Group CEO of Moment Group.

Otto_Drakenberg_porträtt.jpeg

Lars Johansson

Member of the Board

Lars Johansson Brings 30 years of experience from the medtech and pharmaceutical industry, including 13 years as General Manager for Johnson & Johnson in the Nordics. Lars has a track record of being an extraordinary leader and his experience covers all strategic and operational aspects of bringing innovative treatments to patients. 

Lars bild.jpeg

Björn Olsen

Member of the Board

Björn Olsen Professor and Senior Consultant of Infectious Diseases since 2007 at Uppsala University and Academic Hospital. Olsen's scientific publication has (2022) according to Google Scholar over 15,000 citations and an h-index of 60. He is also an ornithologist and expert in bird-borne diseases, including bird flu. In 2010, he published the book "Pandemic". Olsen was the summer host 2006 and 2020 at one of the Swedish radio channels.

bjorn olsen.png
CLINICAL ADVISORY BOARD

Anna Martling, prof.

Clinical advisor

Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003, became a board certified surgeon in 2004 and an associate professor of surgery in 2009. In 2014 Martling became full professor of surgery. Since 2019 she holds the position as Dean at Karolinska Institutet, Stockholm.

She is considered to be a world leading expert in her field and is a frequent lecturer in Sweden and abroad. Professor Martling is Honorary Fellow of Royal College of Surgeon of England,  (FRCS),  American Colleges of Surgeons (FACS) and American Society of Colorectal Surgeons (FASCRS). Professor Martling is chairman of the Swedish Colorectal Cancer Study Group, which is a national research network for colorectal cancer in Sweden. Professor Martling has received numerous awards for her research within the colorectal field and in 2023 she was appointed honorary member of the European Society of Coloproctology (ESCP) which is awarded to individuals who have made an outstanding contribution to the field of coloproctology. 

Photo from Karolinska Institutet.

Anna M.png

Torbjörn Holm, prof.

Clinical advisor

Former surgical professor at Karolinska Institutet, specialising in colorectal surgery. He has brought significant contributions to the  development of the multidisciplinary treatment of colorectal cancer in Sweden. 

torbjorn_holm.webp
SURGICAL ADVISORY BOARD

Torbjörn Holm, prof.

Surgical advisor

Former surgical professor at Karolinska Institutet, specialising in colorectal surgery. He has brought significant contributions to the  development of the multidisciplinary treatment of colorectal cancer in Sweden. 

torbjorn_holm.webp

Niels Qvist, prof.

Surgical advisor

Became a surgeon in 1988 and is now Head of Research at the unit for Gastroenterology Surgery at Odense University Hospital. He has published over 300 peer reviewed medical journals and holds big international network. 

Niels Qvist.jpg

André D'Hoore, prof. 

Surgical advisor

Started as a surgeon in 1994 and is now one of Europe's leading surgeons with a big international network and post doc training at leading clinics such as Cleveland Clinic in Fort Lauderdale, St Mark's Hospital in London and the Hôpital Cantonal in Geneva. Experienced in handling new medical technologies and publishing studies. His clinical work has resulted in over 160 peer reviewed articles. 

Prof Andrè D`Hoore.jpg
FINANCIAL ADVISORY BOARD

Johan Stein

Financial advisor

Lecturer and researcher at Stockholm School of Economics for 10 years. He gained a doctorate degree in 2011, later named docent and professor. Has been Head of research and portfolio manager at a number of hedge funds and with Nordea Investment Management. Also has experience from Alfred Berg and BNP Paribas.

johan-stein.jpg

Christophe Genetay

Financial advisor

M.Sc. Civ Eng. and has 25 years experience in the financial industry, working with listed and non-listed companies. Former head of training at the Swedish Council for small investors. Since 2013 been engaged with Investor Relations across various industries.

christophe.jpg
Q&R

Quality and Regulatory

C-REX® devices are CE-marked in Europe. Regulatory approval has been achieved by complying with Medical Device Directive 93/42/EC as Class IIa devices and CarpoNovum holds a certificate of current version of EN ISO 13485.

Quality policy

All team members of CarpoNovum are committed to improve lives of people undergoing colorectal surgery, by providing high-quality, safe and effective products and services that meet our customers’ needs, with focus on continual improvement, by:
 

  • having a close collaboration with leading surgeons and health care professionals

  • complying with all applicable regulatory requirements

  • continually improving the effectiveness of our Quality Management System

  • periodically reviewing the performance of the Quality Management System and our Quality Objectives

  • communicating this Quality Policy to all team members, subcontractors and suppliers to assure that it is understood and implemented


 

Quality & Regulatory
bottom of page